Author： Boster Aaron Ankeny Daniel P. Racke Michael K.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.70, Iss.18, 2010-12, pp. : 2343-2356
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
B Cell-Targeted Therapies for Systemic Lupus Erythematosus: An Update on Clinical Trial Data
Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. :
Activation of B Cells by a Dendritic Cell-Targeted Oral Vaccine
Current Pharmaceutical Biotechnology, Vol. 14, Iss. 10, 2013-01 ,pp. :
B Cell-Targeted Therapy for Rheumatoid Arthritis: An Update on the Evidence
Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. :
Emerging therapies in multiple sclerosis
By Farrell Rachel Heaney Dominic Giovannoni Gavin
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :